Psychiatric Emergencies Flashcards
What is the aetiology of NMS?
NMS is commonly due to antipsychotic medications, particularly FGA (e.g haloperidol).
Symptoms arise due to blockage of D2 receptors in the nigrostriatal pathway and hypothalamus.
Clinical symptoms of NMS?
F - fever
A - autonomic dysfunction (eg. labile BP, tachycardia)
L - leukocytosis
T - tremour and ataxia
E - elevated enzymes (CK and transaminases)
R - rigours
Symptoms usually develop 10-14 days after commencement of medication.
Investigations for NMS.
- urine toxicology screen
- blood glucose levels
- FBC
- Inflammatory markers
- UECs
- LFTs
- CK
- ECG
- ABG
Management of NMS.
- Primary survey —> ABCDE
- Cessation of offending agent
- Supportive measures (eg. ice packs, cooling agents)
- Pharmacotherapy:
- daltrolene —> inhibits release of Ca++ from sarcoplasmic reticulum, thus preventing rigours and muscle contraction / spasticity
- bromocriptime —> D2 receptor agonist
What is the aetiology of SEROTONIN SYNDROME?
Serotonin syndrome is often caused by concurrent use of multiple serotonergic medications. This includes:
- SSRIs
- SNRIs
- TCAs
- MAO inhibitors
It can also occur when there is a change in medication without appropriate tapering.
Clinical symptoms of serotonin syndrome?
H - hyperthermia
A - autonomic instability
R - raised blood pressure
M - myoclonus + rigidity + increased reflexes
SS typically comes on within 24 hours (much more acute compared to NMS).
Investigations for SS?
Investigation findings for SS will be non-specific.
Investigations may include:
- FBC
- Inflammatory markers
- UECs
- LFTs
- CK
- ECG
- ABG
Management for SS?
- Primary survey —> ABCDE
- Cessation of offending agent
- Supportive measures (eg. ice packs, cooling agents)
- Pharmacotherapy:
- cyproheptadine —> anti histamine with anti-serotonin properties at high doses
PARACETAMOL OVERDOSE
- maximum dose
- clinical presentation
- key investigations
- management
MAXIMUM DOSE - 4g / day (note that 10g / day is considered the “overdose” amount)
CLINICAL PRESENTATION:
Day 0-1 —> asymptomatic, non-specific N+V
Day 1-2 —> RUQ pain, jaundice, N+V
Day 3-4 —> fulminant hepatic failure (encephalopathy, coagulopathy, bruising)
NB LFTs should return to normal within 3 months.
KEY INVESTIGATIONS ✔️ serum paracetamol levels at presentation and four hours ✔️ FBC and WCC ✔️ inflammatory markers ✔️ UECs ✔️ LFTs ✔️ coags ✔️ urine toxicology screen
ANTIDOTE - N-acetyl-cystine (NAC)
✔️ give if plasma paractamol levels > 153 mg / L at any time or if serum levels are above normal at 4 hours
OPIOID OVERDOSE
- maximum dose
- clinical presentation
- key investigations
- management
MAXIMUM DOSE - variable; depends on previous exposure, body mass, drug interactions etc.
PRESENTATION - clinical triad of
- reduced GCS
- respiratory depression
- pinpoint pupils
KEY INVESTIGATIONS ✔️ vital signs (particularly respiratory rate and O2 %) ✔️ FBC and WCC ✔️ UECs and LFTs ✔️ coags ✔️ urine + blood toxicology screen
ANTIDOTE - naloxone IM or IV (acts as a complete opioid receptor antagonist)
TRICYCLIC ANTIDEPRESSANT OVERDOSE
- maximum dose
- clinical presentation
- key investigations
- management
MAXIMUM DOSE - 10mg / kg per day is potentially life-threatening
✔️ >30mg / kg per day can cause severe cardio toxicity and coma for > 24 hours
CLINICAL PRESENTATION 1. Anticholinergic effects ✔️ blurred vision ✔️ dilated pupils ✔️ urinary and feacal retention ✔️ dry mouth ✔️ myoclonic jerks
- Reduced catecholamine uptake
✔️ postural hypotension
✔️ tachycardia - Inhibition of fast Na+ channels
✔️ arrythmia
✔️ widening of QRS complexes
✔️ broad complex tachycardia
4 CNS side effects
✔️ sedation and coma
✔️ seizure
✔️ delirium
KEY INVESTIGATIONS ✔️ FBC and WCC ✔️ inflammatory markers ✔️ UECs and LFTs ✔️ lipids ✔️ coags ✔️ TFTs ✔️ lipase + amylase
MANAGEMENT
- If presentation is within 60 mins –> gastric leverage and charcoal
- If presentation is < 60 mins –> give IV sodium bicarbonate to maintain pH > 7.5